Skip to main content
. Author manuscript; available in PMC: 2018 May 7.
Published in final edited form as: Technology (Singap World Sci). 2018 Jan 24;5(4):201–213. doi: 10.1142/S233954781750011X

Figure 5.

Figure 5

(a) Illustration of proposed β cell interaction with NL-2 functionalized SCM. (b) Dose-dependent insulin secretion (normalized to cellular insulin content) from pancreatic β cells after 24-hour incubation with NL-2 functionalized SCMs. Insulin secretion increased with greater number of functionalized SCMs, demonstrating the biomimetic potential of NL-2 functionalized SCMs for antidiabetic therapy (p < 0.01, n = 6). (c) Protein levels from pancreatic β cells after 24-hour incubation with naked and NL-2 functionalized SCMs. NL-functionalized SCMs significantly increased protein levels (p < 0.001, n = 11), further demonstrating the biological activity of NL-2 functionalized SCMs.